ArticleJCO global oncology2020
Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms.
Article in JCO global oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework.British journal of cancer · 2026Article
- Equitable inclusion of diverse populations in oncology clinical trials: deterrents and drivers.ESMO open · 2024Review
- Quantifying the impact of the COVID-19 pandemic on clinical trial screening rates over time in 37 countries.Trials · 2023Article
- External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigations.Frontiers in medicine · 2023Review
- Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022Article
- Report from the Ready for the Next Round Thought-Leadership Roundtables on Building Resilience in Cancer Care and Control in Canada-Colorectal Cancer Canada; 2021.Current oncology (Toronto, Ont.) · 2022Article
- Article
- Decentralized clinical trials (DCTs): A few ethical considerations.Frontiers in public health · 2022Review
- Emerging issues related to COVID-19 vaccination in patients with cancer.Oncology and therapy · 2021Article
- Current Challenges Faced by Cancer Clinical Trials in Addressing the Problem of Under-Representation of Older Adults: A Narrative Review.Oncology and therapy · 2021Review
- COVID-19 and Global Oncology: A Year in Review.JCO global oncology · 2021Article
- Managing children with brain tumors during the COVID-19 era: Don't stop the care!Computational and structural biotechnology journal · 2021Review
- Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.